1.Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial
Yoon Jin CHOI ; Yong Chan LEE ; Jung Mogg KIM ; Jin Il KIM ; Jeong Seop MOON ; Yun Jeong LIM ; Gwang Ho BAIK ; Byoung Kwan SON ; Hang Lak LEE ; Kyoung Oh KIM ; Nayoung KIM ; Kwang Hyun KO ; Hye-Kyung JUNG ; Ki-Nam SHIM ; Hoon Jai CHUN ; Byung-Wook KIM ; Hyuk LEE ; Jie-Hyun KIM ; Hyunsoo CHUNG ; Sang Gyun KIM ; Jae Young JANG
Gut and Liver 2022;16(4):535-546
Background/Aims:
We examined the efficacy and safety of tegoprazan as a part of first-line triple therapy for Helicobacter pylori eradication.
Methods:
A randomized, double-blind, controlled, multicenter study was performed to evaluate whether tegoprazan (50 mg)-based triple therapy (TPZ) was noninferior to lansoprazole (30 mg)-based triple therapy (LPZ) (with amoxicillin 1 g and clarithromycin 500 mg; all administered twice daily for 7 days) for treating H. pylori. The primary endpoint was the H. pylori eradication rate. Subgroup analyses were performed according to the cytochrome P450 (CYP) 2C19 genotype, the minimum inhibitory concentration (MIC) of amoxicillin and clarithromycin, and underlying gastric diseases.
Results:
In total, 350 H. pylori-positive patients were randomly allocated to the TPZ or LPZ group. The H. pylori eradication rates in the TPZ and LPZ groups were 62.86% (110/175) and 60.57% (106/175) in an intention-to-treat analysis and 69.33% (104/150) and 67.33% (101/150) in a per-protocol analysis (non-inferiority test, p=0.009 and p=0.013), respectively. Subgroup analyses according to MICs or CYP2C19 did not show remarkable differences in eradication rate. Both first-line triple therapies were well-tolerated with no notable differences.
Conclusions
TPZ is as effective as proton pump inhibitor-based triple therapy and is as safe as first-line H. pylori eradication therapy but does not overcome the clarithromycin resistance of H. pylori in Korea
2.Drug hypersensitivity reactions in Asia: regional issues and challenges
Bernard Yu Hor THONG ; Michaela LUCAS ; Hye Ryun KANG ; Yoon Seok CHANG ; Philip Hei LI ; Min Moon TANG ; James YUN ; Jie Shen FOK ; Byung Keun KIM ; Mizuho NAGAO ; Iris RENGGANIS ; Yi Giien TSAI ; Wen Hung CHUNG ; Masao YAMAGUCHI ; Ticha RERKPATTANAPIPAT ; Wasu KAMCHAISATIAN ; Ting Fan LEUNG ; Ho Joo YOON ; Luo ZHANG ; Amir Hamzah Abdul LATIFF ; Takao FUJISAWA ; Francis THIEN ; Mariana C CASTELLS ; Pascal DEMOLY ; Jiu Yao WANG ; Ruby PAWANKAR
Asia Pacific Allergy 2020;10(1):8-
There are geographical, regional, and ethnic differences in the phenotypes and endotypes of patients with drug hypersensitivity reactions (DHRs) in different parts of the world. In Asia, aspects of drug hypersensitivity of regional importance include IgE-mediated allergies and T-cell-mediated reactions, including severe cutaneous adverse reactions (SCARs), to beta-lactam antibiotics, antituberculous drugs, nonsteroidal anti-inflammatory drugs (NSAIDs) and radiocontrast agents. Delabeling of low-risk penicillin allergy using direct oral provocation tests without skin tests have been found to be useful where the drug plausibility of the index reaction is low. Genetic risk associations of relevance to Asia include human leucocyte antigen (HLA)-B*1502 with carbamazepine SCAR, and HLA-B*5801 with allopurinol SCAR in some Asian ethnic groups. There remains a lack of safe and accurate diagnostic tests for antituberculous drug allergy, other than relatively high-risk desensitization regimes to first-line antituberculous therapy. NSAID hypersensitivity is common among both adults and children in Asia, with regional differences in phenotype especially among adults. Low dose aspirin desensitization is an important therapeutic modality in individuals with cross-reactive NSAID hypersensitivity and coronary artery disease following percutaneous coronary intervention. Skin testing allows patients with radiocontrast media hypersensitivity to confirm the suspected agent and test for alternatives, especially when contrasted scans are needed for future monitoring of disease relapse or progression, especially cancers.
Adult
;
Allopurinol
;
Anaphylaxis
;
Anti-Bacterial Agents
;
Asia
;
Asian Continental Ancestry Group
;
Aspirin
;
Asthma
;
Carbamazepine
;
Child
;
Cicatrix
;
Contrast Media
;
Coronary Artery Disease
;
Diagnostic Tests, Routine
;
Drug Hypersensitivity
;
Ethnic Groups
;
Humans
;
Hypersensitivity
;
Penicillins
;
Percutaneous Coronary Intervention
;
Phenotype
;
Recurrence
;
Skin Tests
3.Poor Prognostic Factors in Patients with Parenteral Nutrition-Dependent Pediatric Intestinal Failure.
Shin Jie CHOI ; Kyung Jae LEE ; Jong Sub CHOI ; Hye Ran YANG ; Jin Soo MOON ; Ju Young CHANG ; Jae Sung KO
Pediatric Gastroenterology, Hepatology & Nutrition 2016;19(1):44-53
PURPOSE: Parenteral nutrition (PN) not only provides nutritional support but also plays a crucial role in the treatment of children with intestinal failure. The aim of this study was to evaluate the clinical significance and clinical outcomes of long-term PN. METHODS: Retrospective cohort study was conducted using the medical records of patients treated at Seoul National University Children's Hospital. This study included 19 patients who received PN for over six months. Most patients received home PN. RESULTS: The indications for PN included short bowel syndrome, chronic intestinal pseudo-obstruction, and intractable diarrhea of infancy. The median age of PN initiation was 1.3 years, and the median treatment duration was 2.9 years. Two patients were weaned from PN; 14 continued to receive PN with enteral feedings; and 3 patients died. The overall survival rates at 2 and 5 years were 93.3% and 84.0%, respectively. The incidence of catheter-related bloodstream infections was 2.7/1,000 catheter-days and was associated with younger age at PN initiation and lower initial height Z-score. Six patients developed catheter-related central vein thrombosis, with an incidence of 0.25/1,000 catheter-days. Eleven patients experienced PN-associated liver disease (PNALD), and one patient underwent multi-visceral transplant. The patients with PNALD exhibited lower final heights and body weight Z-scores. All patients experienced micronutrient deficiencies transiently while receiving PN. CONCLUSION: PN is an important and safe treatment for pediatric intestinal failure. PNALD was linked to final anthropometric poor outcomes. Micronutrient deficiencies were common. Anthropometric measurements and micronutrient levels must be monitored for successful PN completion.
Body Weight
;
Catheter-Related Infections
;
Child
;
Cholestasis
;
Cohort Studies
;
Diarrhea
;
Humans
;
Incidence
;
Intestinal Pseudo-Obstruction
;
Liver Diseases
;
Medical Records
;
Micronutrients
;
Nutritional Support
;
Parenteral Nutrition
;
Retrospective Studies
;
Seoul
;
Short Bowel Syndrome
;
Survival Rate
;
Thrombosis
;
Veins
4.Stepwise Endoscopy Based on Sigmoidoscopy in Evaluating Pediatric Graft-versus-Host Disease.
Kyung Jae LEE ; Shin Jie CHOI ; Hye Ran YANG ; Ju Yuong CHANG ; Hyoung Jin KANG ; Hee Young SHIN ; Gyeong Hoon KANG ; Jae Sung KO ; Jin Soo MOON
Pediatric Gastroenterology, Hepatology & Nutrition 2016;19(1):29-37
PURPOSE: The aim of our study was to establish a safe and convenient diagnostic method for acute gastrointestinal (GI) graft-versus-host disease (GVHD) in children by determining the sensitivity and negative predictive values of upper and lower endoscopic biopsies for children suspected of GI GVHD. METHODS: Patients suspected of GI GVHD who received endoscopic evaluation within 100 days after stem cell transplantation and endoscopies between January 2012 and March 2014 in Seoul National University Children's Hospital were included in our study. RESULTS: Fifteen patients with a total of 20 endoscopic procedures were included in our study. Sensitivity at the esophagus, stomach, and duodenum were 22.2%, 30.0%, and 80.0%, respectively. Negative predictive values at the esophagus, stomach, and duodenum were 22.2%, 30.0%, and 60.0%, respectively. Overall sensitivity and negative predictive values of upper endoscopic biopsy for GVHD were 77.8% and 50.0%, respectively. Overall sensitivity and negative predictive values of lower endoscopic biopsy for GVHD were 88.9% and 66.7%, respectively. CONCLUSION: We recommend flexible sigmoidoscopy as a safe and accurate diagnostic tool for GVHD, similar to other studies reported previously. However, if there is no evidence of GVHD on sigmoidoscopy with high index of suspicion of GI bleeding, full colonoscopy and upper endoscopy should be considered.
Biopsy
;
Child
;
Colonoscopy
;
Duodenum
;
Endoscopy*
;
Esophagus
;
Graft vs Host Disease*
;
Hemorrhage
;
Humans
;
Seoul
;
Sigmoidoscopy*
;
Stem Cell Transplantation
;
Stomach
5.Successful rapid desensitization for cetuximab-induced anaphylaxis.
Ha Kyeong WON ; Sung Do MOON ; Ji Su SHIM ; Soo Jie CHUNG ; Gun Woo KIM ; Su Jeong KIM ; Han Ki PARK ; Hye Ryun KANG
Allergy, Asthma & Respiratory Disease 2015;3(4):294-296
Cetuximab, a chimeric mouse-human immunoglobulin, is an antiepidermal growth factor receptor monoclonal antibody. It has been approved by the U.S. Food and Drug Administration for the treatment of metastatic colorectal and head/neck cancer, but can cause fatal hypersensitivity reactions in some patients. A 66-year-old male with metastatic sigmoid cancer had cetuximab-induced anaphylaxis when the first dose of cetuximab was administered. Cetuximab was safely readministered for another 15 cycles based on the rapid desensitization protocol. We experienced a case of cetuximab-induced anaphylaxis on the first exposure which was successfully managed by rapid desensitization.
Aged
;
Anaphylaxis*
;
Desensitization, Immunologic
;
Humans
;
Hypersensitivity
;
Immunoglobulins
;
Male
;
Sigmoid Neoplasms
;
United States Food and Drug Administration
;
Cetuximab
6.Clinical Manifestations and Treatment Outcomes of Eosinophilic Gastroenteritis in Children.
Jong Sub CHOI ; Shin Jie CHOI ; Kyung Jae LEE ; Ahlee KIM ; Jung Kyung YOO ; Hye Ran YANG ; Jin Soo MOON ; Ju Young CHANG ; Jae Sung KO ; Gyeong Hoon KANG
Pediatric Gastroenterology, Hepatology & Nutrition 2015;18(4):253-260
PURPOSE: The aim of the present study was to investigate the clinical features and outcome of eosinophilic gastroenteritis (EGE) in children. METHODS: Our study enrolled 24 children who were diagnosed with EGE from 1993 to 2014 at the Department of Pediatrics, Seoul National University Children's Hospital. The patients' clinical manifestations, treatments, and outcomes were reviewed from the medical records. RESULTS: The mean age at diagnosis was 5.3 years. Most patients had gastrointestinal symptoms including diarrhea (54.2%) and abdominal pain (45.8%). Peripheral eosinophilia was present in 91.7% of the patients. Thirteen patients (54.2%) showed anemia, and 15 patients (62.5%) had hypoalbuminemia. EGE was classified as mucosal, subserosal, or muscular in 75.0%, 20.8%, and 4.2% of cases, respectively. Three patients showed gastroduodenal ulcers upon endoscopic analysis. A history of allergy was reported in 13 patients, including atopic dermatitis, allergic rhinitis, and asthma. Five patients (20.8%) improved with food restrictions. Among the 19 patients treated with steroids, 11 (57.9%) discontinued steroid treatment without subsequent relapse, 4 (21.1%) relapsed after ceasing steroid treatment, and 4 (21.1%) showed no response to steroids. Two patients who were resistant to steroids underwent therapeutic surgery. The presence of gastroduodenal ulcers was significantly associated with relapse and steroid resistance. CONCLUSION: A high suspicion of EGE is warranted when children have nonspecific gastrointestinal symptoms and peripheral eosinophilia. Most patients improved with food restrictions or steroid treatment, although one-third of patients showed a relapse or steroid resistance.
Abdominal Pain
;
Anemia
;
Asthma
;
Child*
;
Dermatitis, Atopic
;
Diagnosis
;
Diarrhea
;
Eosinophilia
;
Eosinophils*
;
Gastroenteritis*
;
Humans
;
Hypersensitivity
;
Hypoalbuminemia
;
Medical Records
;
Pediatrics
;
Peptic Ulcer
;
Recurrence
;
Rhinitis
;
Seoul
;
Steroids
;
Ulcer
7.Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions.
Jie SHA ; Jungsik NA ; Jung Ok LEE ; Nami KIM ; Soo Kyung LEE ; Ji Hae KIM ; Ji Wook MOON ; Su Jin KIM ; Hye Jeong LEE ; Jong Il CHOI ; Sun Hwa PARK ; Hyeon Soo KIM
Endocrinology and Metabolism 2014;29(3):363-370
BACKGROUND: The role of small GTPase molecules is poorly understood under high glucose conditions. METHODS: We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose. RESULTS: We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake. CONCLUSION: These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.
AMP-Activated Protein Kinases
;
Blotting, Western
;
Glucose*
;
GTP Phosphohydrolases
;
Guanine Nucleotide Exchange Factors
;
Metformin
;
Muscle, Skeletal
;
Paxillin
;
Phosphorylation
;
RNA, Messenger
;
Signal Transduction
8.Myocardial Ischemia Caused by Paroxysmal Supraventricular Tachycardia in a Patient with Anomalous Origin of Right Coronary Artery Arising from Left Sinus of Valsalva.
Sang Hee SONG ; Seong Eun SUH ; Sun Mi JIN ; Jie Hye MOON ; Yun Kyung CHO ; Sang Wook LIM
Korean Circulation Journal 2013;43(2):123-126
Anomalous origin of a coronary artery is rare and does not generally lead to myocardial infarction and paroxysmal supraventricular tachycardia (PSVT). We report an uncommon case of anomalous origin of the right coronary artery (RCA) originating from the left sinus of Valsalva with PSVT and myocardial ischemia. A 58-year-old man presented with PSVT. After arrhythmia subsided, electrocardiogram showed ST and T wave abnormalities, and transient cardiac enzymes were found to be elevated. Coronary CT angiography confirmed that there was anomalous origin of the RCA originating from the left sinus of Valsalva and no intracoronary stenotic lesion. He was managed with conservative treatment, having no symptoms on clinical follow-up for 4 years.
Angiography
;
Arrhythmias, Cardiac
;
Coronary Vessel Anomalies
;
Coronary Vessels
;
Electrocardiography
;
Follow-Up Studies
;
Humans
;
Multidetector Computed Tomography
;
Myocardial Infarction
;
Myocardial Ischemia
;
Sinus of Valsalva
;
Tachycardia, Paroxysmal
;
Tachycardia, Supraventricular
9.Myocardial Ischemia Caused by Paroxysmal Supraventricular Tachycardia in a Patient with Anomalous Origin of Right Coronary Artery Arising from Left Sinus of Valsalva.
Sang Hee SONG ; Seong Eun SUH ; Sun Mi JIN ; Jie Hye MOON ; Yun Kyung CHO ; Sang Wook LIM
Korean Circulation Journal 2013;43(2):123-126
Anomalous origin of a coronary artery is rare and does not generally lead to myocardial infarction and paroxysmal supraventricular tachycardia (PSVT). We report an uncommon case of anomalous origin of the right coronary artery (RCA) originating from the left sinus of Valsalva with PSVT and myocardial ischemia. A 58-year-old man presented with PSVT. After arrhythmia subsided, electrocardiogram showed ST and T wave abnormalities, and transient cardiac enzymes were found to be elevated. Coronary CT angiography confirmed that there was anomalous origin of the RCA originating from the left sinus of Valsalva and no intracoronary stenotic lesion. He was managed with conservative treatment, having no symptoms on clinical follow-up for 4 years.
Angiography
;
Arrhythmias, Cardiac
;
Coronary Vessel Anomalies
;
Coronary Vessels
;
Electrocardiography
;
Follow-Up Studies
;
Humans
;
Multidetector Computed Tomography
;
Myocardial Infarction
;
Myocardial Ischemia
;
Sinus of Valsalva
;
Tachycardia, Paroxysmal
;
Tachycardia, Supraventricular
10.Endoscopic Resection of Giant Colonic Lipoma: Case Series with Partial Resection.
Gun Woo KIM ; Chang Il KWON ; Sang Hee SONG ; Sun Mi JIN ; Kyung Ho KIM ; Jie Hye MOON ; Sung Pyo HONG ; Pil Won PARK
Clinical Endoscopy 2013;46(5):586-590
Colonic lipoma, a very rare form of benign tumor, is typically detected incidentally in asymptomatic patients. The size of lipoma is reported variously from 2 mm to 30 cm, with higher likelihood of symptoms as the size is bigger. Cases with symptom or bigger lesion are surgically resected in principle; endoscopic resection, which has developed recently with groundbreaking advance of endoscopic excision technology, is being used more often but with rare report of success due to high chance of complications such as bowel perforation or bleeding. The authors report here, together with a literature review, our experiences of three cases of giant colonic lipomas showing complete remission after aggressive unroofing technique, at certain intervals, using snare catheter at the origin of the lipoma so that the remaining lipoma could be drained out of the exposed surface spontaneously, in order to reduce complications.
Catheters
;
Colon
;
Colonoscopy
;
Hemorrhage
;
Humans
;
Lipoma
;
SNARE Proteins

Result Analysis
Print
Save
E-mail